Search research articles
Contact Us
Filters
Showing results (31-40 of 36) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 36 results.
Cell Reports. Medicine
|
March 20, 2025
Practical microenvironment classification in diffuse large B cell lymphoma using digital pathology
Yu-Qing Wang, Shuo Wang, Hong-Mei Yi, et al.
Clinical and Translational Medicine
|
April 23, 2025
Response-adapted zanubrutinib and tislelizumab as a potential strategy to enhance CD19 CAR T-cell therapy in relapsed/refractory large B-cell lymphoma: A retrospective observational study
Rong Shen, Wei-Guo Cao, Li Wang, et al.
Cell Reports. Medicine
|
November 19, 2025
A prognostic index integrating deep learning baseline PET/CT biomarkers and multi-omics profiling in diffuse large B cell lymphoma
Yue Wang, Xue Wang, Xin-Yun Huang, et al.
Science Bulletin
|
October 5, 2023
GPCR signaling contributes to immune characteristics of microenvironment and process of EBV-induced lymphomagenesis
Jie Xiong, Yu-Ting Dai, Wen-Fang Wang, et al.
Ebiomedicine
|
April 11, 2025
Molecular heterogeneity of CD30<sup>+</sup> peripheral T-cell lymphoma with prognostic significance and therapeutic implications: a retrospective multi-centre study
Yu-Jia Huo, Shu Cheng, Hong-Mei Yi, et al.
Molecular Biomedicine
|
December 9, 2025
Clinicopathological characteristics, genetic aberrations, and optimized treatment strategies in double-hit and triple-hit lymphoma: a multi-center cohort study
Yi-Ge Shen, Meng-Meng Ji, Qing Shi, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 36) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 36 results.
Cell Reports. Medicine
|
March 20, 2025
Practical microenvironment classification in diffuse large B cell lymphoma using digital pathology
Yu-Qing Wang, Shuo Wang, Hong-Mei Yi, et al.
Clinical and Translational Medicine
|
April 23, 2025
Response-adapted zanubrutinib and tislelizumab as a potential strategy to enhance CD19 CAR T-cell therapy in relapsed/refractory large B-cell lymphoma: A retrospective observational study
Rong Shen, Wei-Guo Cao, Li Wang, et al.
Cell Reports. Medicine
|
November 19, 2025
A prognostic index integrating deep learning baseline PET/CT biomarkers and multi-omics profiling in diffuse large B cell lymphoma
Yue Wang, Xue Wang, Xin-Yun Huang, et al.
Science Bulletin
|
October 5, 2023
GPCR signaling contributes to immune characteristics of microenvironment and process of EBV-induced lymphomagenesis
Jie Xiong, Yu-Ting Dai, Wen-Fang Wang, et al.
Ebiomedicine
|
April 11, 2025
Molecular heterogeneity of CD30<sup>+</sup> peripheral T-cell lymphoma with prognostic significance and therapeutic implications: a retrospective multi-centre study
Yu-Jia Huo, Shu Cheng, Hong-Mei Yi, et al.
Molecular Biomedicine
|
December 9, 2025
Clinicopathological characteristics, genetic aberrations, and optimized treatment strategies in double-hit and triple-hit lymphoma: a multi-center cohort study
Yi-Ge Shen, Meng-Meng Ji, Qing Shi, et al.
Page
of 4